These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30823477)

  • 1. A Novel Specific Anti-CD73 Antibody Inhibits Triple-Negative Breast Cancer Cell Motility by Regulating Autophagy.
    Qiao Z; Li X; Kang N; Yang Y; Chen C; Wu T; Zhao M; Liu Y; Ji X
    Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30823477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis.
    Stagg J; Divisekera U; McLaughlin N; Sharkey J; Pommey S; Denoyer D; Dwyer KM; Smyth MJ
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1547-52. PubMed ID: 20080644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells.
    Terp MG; Olesen KA; Arnspang EC; Lund RR; Lagerholm BC; Ditzel HJ; Leth-Larsen R
    J Immunol; 2013 Oct; 191(8):4165-73. PubMed ID: 24043904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiamulin inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of CD73.
    Yang X; Pei S; Wang H; Jin Y; Yu F; Zhou B; Zhang H; Zhang D; Lin D
    BMC Cancer; 2017 Apr; 17(1):255. PubMed ID: 28399915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining phenotypic and proteomic approaches to identify membrane targets in a 'triple negative' breast cancer cell type.
    Rust S; Guillard S; Sachsenmeier K; Hay C; Davidson M; Karlsson A; Karlsson R; Brand E; Lowne D; Elvin J; Flynn M; Kurosawa G; Hollingsworth R; Jermutus L; Minter R
    Mol Cancer; 2013 Feb; 12():11. PubMed ID: 23406016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis.
    Stagg J; Divisekera U; Duret H; Sparwasser T; Teng MW; Darcy PK; Smyth MJ
    Cancer Res; 2011 Apr; 71(8):2892-900. PubMed ID: 21292811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of triple negative breast cancer cell migration and metastases formation is prevented by chloroquine in a pre-irradiated mouse model.
    Bouchard G; Therriault H; Geha S; Bérubé-Lauzière Y; Bujold R; Saucier C; Paquette B
    BMC Cancer; 2016 Jun; 16():361. PubMed ID: 27282478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy.
    Turcotte M; Allard D; Mittal D; Bareche Y; Buisseret L; José V; Pommey S; Delisle V; Loi S; Joensuu H; Kellokumpu-Lehtinen PL; Sotiriou C; Smyth MJ; Stagg J
    Cancer Res; 2017 Oct; 77(20):5652-5663. PubMed ID: 28855210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative characterisation of an ecto-5'-nucleotidase (CD73) in non-tumoral MCF10-A breast cells and triple-negative MDA-MB-231 breast cancer cells.
    Rocha-Vieira TC; Lacerda-Abreu MA; Carvalho-Kelly LF; Santos-Araújo S; Gondim KC; Meyer-Fernandes JR
    Cell Biol Int; 2024 Sep; 48(9):1354-1363. PubMed ID: 38894528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial.
    Buisseret L; Pommey S; Allard B; Garaud S; Bergeron M; Cousineau I; Ameye L; Bareche Y; Paesmans M; Crown JPA; Di Leo A; Loi S; Piccart-Gebhart M; Willard-Gallo K; Sotiriou C; Stagg J
    Ann Oncol; 2018 Apr; 29(4):1056-1062. PubMed ID: 29145561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs.
    Allard B; Pommey S; Smyth MJ; Stagg J
    Clin Cancer Res; 2013 Oct; 19(20):5626-35. PubMed ID: 23983257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer.
    Allard B; Turcotte M; Stagg J
    Expert Opin Ther Targets; 2014 Aug; 18(8):863-81. PubMed ID: 24798880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CD73 therapy impairs tumor angiogenesis.
    Allard B; Turcotte M; Spring K; Pommey S; Royal I; Stagg J
    Int J Cancer; 2014 Mar; 134(6):1466-73. PubMed ID: 23982901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer.
    Loi S; Pommey S; Haibe-Kains B; Beavis PA; Darcy PK; Smyth MJ; Stagg J
    Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11091-6. PubMed ID: 23776241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy induces enrichment of CD47
    Samanta D; Park Y; Ni X; Li H; Zahnow CA; Gabrielson E; Pan F; Semenza GL
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1239-E1248. PubMed ID: 29367423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel compound LingH2-10 inhibits the growth of triple negative breast cancer cells in vitro and in vivo as a selective inverse agonist of estrogen-related receptor α.
    Ning Y; Chen H; Du Y; Ling H; Zhang L; Chen L; Qi H; Shi X; Li Q
    Biomed Pharmacother; 2017 Sep; 93():913-922. PubMed ID: 28715872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells.
    Wang L; Zhou X; Zhou T; Ma D; Chen S; Zhi X; Yin L; Shao Z; Ou Z; Zhou P
    J Cancer Res Clin Oncol; 2008 Mar; 134(3):365-72. PubMed ID: 17671792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
    Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
    Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer.
    Petruk N; Tuominen S; Åkerfelt M; Mattsson J; Sandholm J; Nees M; Yegutkin GG; Jukkola A; Tuomela J; Selander KS
    Sci Rep; 2021 Mar; 11(1):6035. PubMed ID: 33727591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo.
    Li HC; Xia ZH; Chen YF; Yang F; Feng W; Cai H; Mei Y; Jiang YM; Xu K; Feng DX
    Cell Physiol Biochem; 2017; 43(5):1829-1840. PubMed ID: 29050003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.